152 related articles for article (PubMed ID: 26522969)
1. Temporal trends in the utilisation of preventive medicines by older people: A 9-year population-based study.
Narayan SW; Tordoff JM; Nishtala PS
Arch Gerontol Geriatr; 2016; 62():103-11. PubMed ID: 26522969
[TBL] [Abstract][Full Text] [Related]
2. Decade-long temporal trends in the utilization of preventive medicines by centenarians.
Narayan SW; Nishtala PS
J Clin Pharm Ther; 2017 Apr; 42(2):165-169. PubMed ID: 27943354
[TBL] [Abstract][Full Text] [Related]
3. Population-based study examining the utilization of preventive medicines by older people in the last year of life.
Narayan SW; Nishtala PS
Geriatr Gerontol Int; 2018 Jun; 18(6):892-898. PubMed ID: 29392866
[TBL] [Abstract][Full Text] [Related]
4. Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack.
Hills NK; Johnston SC
Stroke; 2008 Apr; 39(4):1228-32. PubMed ID: 18323509
[TBL] [Abstract][Full Text] [Related]
5. Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.
Carlsson AC; Wändell P; Gasevic D; Sundquist J; Sundquist K
Int J Cardiol; 2015; 187():547-52. PubMed ID: 25863300
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
7. Does the combination of warfarin and aspirin have a place in secondary stroke prevention? Yes.
Furlan AJ
Stroke; 2009 May; 40(5):1942-3. PubMed ID: 19299635
[No Abstract] [Full Text] [Related]
8. The Efficacy and Safety of 3 Types of Interventions for Stroke Prevention in Patients With Cardiovascular and Cerebrovascular Diseases: A Network Meta-analysis.
Sun Q; Chang S; Lu S; Zhang Y; Chang Y
Clin Ther; 2017 Jul; 39(7):1291-1312.e8. PubMed ID: 28606562
[TBL] [Abstract][Full Text] [Related]
9. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
10. Effect of age, gender, ethnicity, socioeconomic status and region on dispensing of CVD secondary prevention medication in New Zealand: the Atlas of Health Care Variation CVD cohort (VIEW-1).
Kerr A; Exeter D; Hanham G; Grey C; Zhao J; Riddell T; Lee M; Jackson R; Wells S
N Z Med J; 2014 Aug; 127(1400):39-69. PubMed ID: 25145366
[TBL] [Abstract][Full Text] [Related]
11. Outcomes associated with combined antiplatelet and anticoagulant therapy.
Johnson SG; Rogers K; Delate T; Witt DM
Chest; 2008 Apr; 133(4):948-54. PubMed ID: 18198244
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the impact of educational interventions on use of antithrombotics in Australia.
Mandryk JA; Wai A; Mackson JM; Patterson C; Bhasale A; Weekes LM
Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):160-71. PubMed ID: 18098333
[TBL] [Abstract][Full Text] [Related]
14. Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs?
Hankey GJ
Curr Opin Neurol; 2010 Feb; 23(1):65-72. PubMed ID: 19949330
[TBL] [Abstract][Full Text] [Related]
15. Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study.
Lorenzoni R; Lazzerini G; Cocci F; De Caterina R
Am Heart J; 2004 Jul; 148(1):e6. PubMed ID: 15215815
[TBL] [Abstract][Full Text] [Related]
16. The effect of antiplatelet and anticoagulant therapy on the clinical outcome of patients undergoing ureteroscopy.
Toepfer NJ; Baylor K; Henry Y; Simmons J; Berger PB
Urology; 2013 Oct; 82(4):773-9. PubMed ID: 23876586
[TBL] [Abstract][Full Text] [Related]
17. New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.
Rubboli A; Agewall S; Huber K; Lip GY
Int J Cardiol; 2015 Oct; 196():133-8. PubMed ID: 26093527
[TBL] [Abstract][Full Text] [Related]
18. Warfarin and antiplatelet combination use among commercially insured patients enrolled in an anticoagulation management service.
Johnson SG; Witt DM; Eddy TR; Delate T
Chest; 2007 May; 131(5):1500-7. PubMed ID: 17494799
[TBL] [Abstract][Full Text] [Related]
19. Warfarin use in nursing home residents: results from the 2004 national nursing home survey.
Ghaswalla PK; Harpe SE; Slattum PW
Am J Geriatr Pharmacother; 2012 Feb; 10(1):25-36.e2. PubMed ID: 22226690
[TBL] [Abstract][Full Text] [Related]
20. Concordance between clopidogrel use and prescribing guidelines.
Kubler PA; Pillans PI; Marrinan MC; Frogley M
Intern Med J; 2004 Dec; 34(12):663-7. PubMed ID: 15610210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
